Theravance Inc $23.88

down -1.44


24/7/2014 04:00 PM  |  NASDAQ : THRX  
Industries : Drugs / Biotechnology

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
5/09/2014BLUM LEONARD MSr VP, Chief Comm. Officer-18,849$26.86-5.81%
5/09/2014LEE JUNNINGSr. VP, Technical Operations-14,650$26.86-8.39%
5/09/2014Mammen MathaiSVP, Research & Early Clin Dev-22,833$26.86-8.72%
5/09/2014Shafer Bradford JSr VP, Gen. Counsel, Secretary-22,833$26.86-6.27%
5/09/2014Winningham Rick EChief Executive Officer-50,225$26.86-6.67%
5/09/2014Aguiar Michael WSr VP, Chief Financial Officer-21,405$26.86-12.82%
3/21/2014LEVINE ARNOLD JDirector25,806$9.6930.01%
3/06/2014WHITESIDES GEORGE MDirector25,806$9.694.49%
3/06/2014Mammen MathaiSVP, Research & Early Clin Dev29,250$16.0014.98%
3/06/2014Mammen MathaiSVP, Research & Early Clin Dev12,903$12.407.08%
3/03/2014Shafer Bradford JSr VP, Gen. Counsel, Secretary-1,800$37.23-0.55%
3/03/2014Shafer Bradford JSr VP, Gen. Counsel, Secretary-64,006$36.72-16.31%
3/03/2014Shafer Bradford JSr VP, Gen. Counsel, Secretary65,806$9.6920.14%
3/03/2014Shafer Bradford JSr VP, Gen. Counsel, Secretary30,967$9.6910.47%
2/20/2014Winningham Rick EChief Executive Officer-9,297$39.98-1.37%
2/20/2014Mammen MathaiSVP, Research & Early Clin Dev-4,307$39.98-2.31%
2/20/2014LEE JUNNINGSr. VP, Technical Operations-3,854$39.98-2.53%
2/20/2014BLUM LEONARD MSr VP, Chief Comm. Officer-4,311$39.98-1.48%
2/20/2014Aguiar Michael WSr VP, Chief Financial Officer-4,302$39.98-3.22%
2/20/2014Shafer Bradford JSr VP, Gen. Counsel, Secretary-4,310$39.98-1.44%
2/14/2014Mammen MathaiSVP, Research & Early Clin Dev-4,600$40.04-2.41%
2/14/2014Mammen MathaiSVP, Research & Early Clin Dev-30,400$39.26-13.72%
11/20/2013Winningham Rick EChief Executive Officer-10,046$36.40-1.46%
11/20/2013Shafer Bradford JSr VP, Gen. Counsel, Secretary-4,569$36.40-1.50%
11/20/2013Mammen MathaiSVP, Research & Early Clin Dev-4,569$36.40-2.02%
11/20/2013Aguiar Michael WSr VP, Chief Financial Officer-4,569$36.40-3.30%
9/12/2013Winningham Rick EChief Executive Officer-22,353$40.03-3.14%
8/21/2013Mammen MathaiSVP, Research & Early Clin Dev18,750$16.009.02%
8/20/2013Winningham Rick EChief Executive Officer-10,046$35.89-1.39%
8/20/2013Shafer Bradford JSr VP, Gen. Counsel, Secretary-3,773$35.89-1.22%
8/20/2013Mammen MathaiSVP, Research & Early Clin Dev-3,813$35.89-1.80%
8/20/2013Aguiar Michael WSr VP, Chief Financial Officer-4,570$35.89-3.20%
7/30/2013Mammen MathaiSVP, Research & Early Clin Dev-7,000$36.51-3.20%
6/07/2013Shafer Bradford JSr VP, Gen. Counsel, Secretary-31,038$35.04-9.28%
5/29/2013Mammen MathaiSVP, Research & Early Clin Dev4,570$3.102.25%
5/29/2013Mammen MathaiSVP, Research & Early Clin Dev6,451$12.403.11%
5/29/2013Brinkley David LHead of Business Dev.-3,808$35.01-7.25%
5/20/2013BLUM LEONARD MSr VP, Chief Comm. Officer-3,292$37.01-1.14%
5/20/2013Brinkley David LHead of Business Dev.-2,443$37.01-4.44%
5/20/2013Mammen MathaiSVP, Research & Early Clin Dev-3,292$37.01-1.60%
5/20/2013Shafer Bradford JSr VP, Gen. Counsel, Secretary-3,292$37.01-0.97%
5/20/2013Winningham Rick EChief Executive Officer-10,046$37.01-1.39%
5/20/2013Aguiar Michael WSr VP, Chief Financial Officer-4,570$37.01-3.21%
5/13/2013Brinkley David LHead of Business Dev.16,129$34.0029.33%
5/13/2013Brinkley David LHead of Business Dev.-16,129$40.33-22.68%
5/03/2013Brinkley David LHead of Business Dev.16,129$29.6529.33%
5/03/2013Brinkley David LHead of Business Dev.-16,129$34.77-22.68%
4/30/2013Aguiar Michael WSr VP, Chief Financial Officer-10,100$34.34-6.62%
4/30/2013Mammen MathaiSVP, Research & Early Clin Dev-6,800$33.72-3.19%
4/30/2013Winningham Rick EChief Executive Officer385,161$9.6965.07%
4/30/2013Winningham Rick EChief Executive Officer-253,955$33.64-25.99%
4/30/2013Winningham Rick EChief Executive Officer-1,577$34.32-0.22%
4/30/2013Mammen MathaiSVP, Research & Early Clin Dev-200$34.34-0.10%
4/30/2013Aguiar Michael WSr VP, Chief Financial Officer-160,779$33.77-51.31%
4/30/2013Aguiar Michael WSr VP, Chief Financial Officer170,879$17.91119.93%
4/30/2013Brinkley David LHead of Business Dev.-100$34.35-0.18%
4/30/2013Brinkley David LHead of Business Dev.-17,004$33.76-23.58%
4/30/2013Brinkley David LHead of Business Dev.8,333$6.1513.07%
2/20/2013Mammen MathaiSVP, Research & Early Clin Dev-7,000$22.14-3.18%
2/20/2013Mammen MathaiSVP, Research & Early Clin Dev-5,002$22.10-2.22%
2/20/2013Shafer Bradford JSr VP, Gen. Counsel, Secretary-5,004$22.10-1.46%
2/20/2013Winningham Rick EChief Executive Officer-10,655$22.10-1.77%
2/20/2013Brinkley David LHead of Business Dev.-3,416$22.10-5.08%
1/11/2013Mammen MathaiSVP, Research & Early Clin Dev11,855$3.105.76%
1/11/2013Mammen MathaiSVP, Research & Early Clin Dev2,655$3.101.22%
11/20/2012Brinkley David LHead of Business Dev.-3,054$21.08-4.68%
11/20/2012Shafer Bradford JSr VP, Gen. Counsel, Secretary-4,874$21.08-1.42%
11/20/2012Mammen MathaiSVP, Research & Early Clin Dev-4,874$21.08-2.31%
11/14/2012Mammen MathaiSVP, Research & Early Clin Dev5,161$3.102.51%
11/02/2012Mammen MathaiSVP, Research & Early Clin Dev-6,800$21.42-3.20%
11/02/2012Mammen MathaiSVP, Research & Early Clin Dev-200$22.53-0.10%
8/27/2012Aguiar Michael WSr VP, Chief Financial Officer-17,700$27.24-11.57%
8/27/2012Aguiar Michael WSr VP, Chief Financial Officer-2,861$27.86-2.11%
8/24/2012Aguiar Michael WSr VP, Chief Financial Officer-4,121$28.01-2.62%
8/24/2012Brinkley David LHead of Business Dev.-3,483$27.50-5.47%
8/24/2012Aguiar Michael WSr VP, Chief Financial Officer4,121$17.912.69%
8/20/2012Winningham Rick EChief Executive Officer-10,681$27.01-1.81%
8/20/2012Shafer Bradford JSr VP, Gen. Counsel, Secretary-4,596$27.01-1.34%
8/20/2012Mammen MathaiSVP, Research & Early Clin Dev-4,644$27.01-2.19%
8/20/2012Brinkley David LHead of Business Dev.-3,057$27.01-4.58%
8/20/2012Aguiar Michael WSr VP, Chief Financial Officer-4,877$27.01-3.09%
8/13/2012Mammen MathaiSVP, Research & Early Clin Dev-3,108$26.15-1.44%
8/13/2012Mammen MathaiSVP, Research & Early Clin Dev-21,892$25.68-9.23%
8/07/2012Aguiar Michael WSr VP, Chief Financial Officer-60,000$27.04-27.53%
8/07/2012Aguiar Michael WSr VP, Chief Financial Officer60,000$16.2537.99%
8/03/2012Winningham Rick EChief Executive Officer-39,549$27.77-5.93%
8/03/2012Winningham Rick EChief Executive Officer64,516$3.1010.71%
8/03/2012Winningham Rick EChief Executive Officer80,645$3.1015.45%
8/03/2012Winningham Rick EChief Executive Officer-36,200$28.15-5.77%
8/03/2012Brinkley David LHead of Business Dev.91,667$6.15109.20%
8/03/2012Brinkley David LHead of Business Dev.15,090$18.378.59%
8/03/2012Brinkley David LHead of Business Dev.-123,917$27.92-64.98%
8/03/2012GLAXOSMITHKLINE PLCSubstantial Shareholder316,334$28.211.23%
7/30/2012BLUM LEONARD MSr VP, Chief Comm. Officer-7,546$29.69-2.63%
5/29/2012Aguiar Michael WSr VP, Chief Financial Officer-20,000$22.29-11.24%
5/20/2012Brinkley David LHead of Business Dev.-2,402$20.33-2.78%
5/20/2012Shafer Bradford JSr VP, Gen. Counsel, Secretary-3,832$20.33-1.11%
5/20/2012Mammen MathaiSVP, Research & Early Clin Dev-3,832$20.33-1.59%
5/20/2012Aguiar Michael WSr VP, Chief Financial Officer-3,832$20.33-2.11%
5/20/2012Winningham Rick EChief Executive Officer-10,681$20.33-2.01%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (THRX), click here.
Trading Center